These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27657463)

  • 1. Effect of ivabradine on central aortic blood pressure in patients with stable coronary artery disease: What do we know?
    Lopatin YM; Vitale C
    Int J Cardiol; 2016 Dec; 224():145-148. PubMed ID: 27657463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
    Dillinger JG; Maher V; Vitale C; Henry P; Logeart D; Manzo Silberman S; Allée G; Levy BI
    Hypertension; 2015 Dec; 66(6):1138-44. PubMed ID: 26418022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease.
    Rimoldi SF; Messerli FH; Cerny D; Gloekler S; Traupe T; Laurent S; Seiler C
    Hypertension; 2016 Jun; 67(6):1205-10. PubMed ID: 27091900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
    Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.
    Porres-Aguilar M; Muñoz OC; Abbas A
    Curr Cardiol Rep; 2016 Feb; 18(2):13. PubMed ID: 26768739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.
    Deedwania P
    Drugs; 2013 Sep; 73(14):1569-86. PubMed ID: 24065301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease.
    Hohneck AL; Fries P; Ströder J; Schneider G; Wagenpfeil S; Schirmer SH; Böhm M; Laufs U; Custodis F
    J Hypertens; 2019 May; 37(5):1023-1031. PubMed ID: 30672832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
    Borer JS; Deedwania PC; Kim JB; Böhm M
    Am J Cardiol; 2016 Dec; 118(12):1948-1953. PubMed ID: 27780557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A; de Silva R
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivabradine: recent and potential applications in clinical practice.
    Riccioni G
    Expert Opin Pharmacother; 2011 Feb; 12(3):443-50. PubMed ID: 21254949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
    Canet E; Lerebours G; Vilaine JP
    Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J; Varela A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivabradine: from molecular basis to clinical effectiveness.
    Riccioni G
    Adv Ther; 2010 Mar; 27(3):160-7. PubMed ID: 20419486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy.
    Lupi A; Rognoni A; Cavallino C; Secco GG; Rosso R; Bongo AS
    Cardiovasc Hematol Agents Med Chem; 2015; 13(1):4-9. PubMed ID: 25544120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine in acute coronary syndromes: Protection beyond heart rate lowering.
    Niccoli G; Borovac JA; Vetrugno V; Camici PG; Crea F
    Int J Cardiol; 2017 Jun; 236():107-112. PubMed ID: 28256323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Ivabradine versus β-Blockers for Heart Rate Reduction during Computed Tomography Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
    Qiu S; Shi S; Ping H; Zhou S; Wang H; Yang B
    Cardiology; 2016; 135(3):133-140. PubMed ID: 27328446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine: the hope for a good treatment of ischemic heart disease.
    Riccioni G
    Curr Med Chem; 2013; 20(14):1817-23. PubMed ID: 23394554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.
    Rosano GM; Vitale C; Volterrani M
    Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention.
    Godino C; Colombo A; Margonato A
    Clin Drug Investig; 2017 Feb; 37(2):105-120. PubMed ID: 27766510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.